15hon MSN
Dr. Andrew Campbell is a fellow in the University of Toledo’s Hematology-Oncology program. He has been placed on ...
PRINCETON, N.J., Feb. 13, 2025 (GLOBE NEWSWIRE) -- Sonnet BioTherapeutics Holdings, Inc. (NASDAQ:SONN) (the "Company" or "Sonnet"), a clinical-stage company developing targeted immunotherapeutic drugs ...
Sonnet BioTherapeutics (SONN) announced the appointment of Stephen McAndrew, Ph.D., as Chief Business Officer, effective February 17, 2025.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results